• SENSEX 80,924.43
    33.41 (+0.04%)
  • BANKNIFTY 56,084.90
    -444.00 (--0.79%)
  • Larsen & Toubro
    3,452.00 3,963.00(%)
  • Vimta Labs
    709.00 677.70(%)
  • Waaree Energies
    3,291.95 3,740.75(%)
  • Paradeep Phosph.
    234.05 205.60(%)
  • Jayaswal Neco
    49.42 55.34(%)
  • Kajaria Ceramics
    1,181.60 1,578.25(%)
  • Mazagon Dock
    2,644.90 1,917.95(%)
  • Bharti Airtel
    1,914.90 2,045.50(%)
  • Bharat Electron
    378.25 240.15(%)
  • Go Digit General
    374.60 407.55(%)
  • Tata Chemicals
    999.00 1,244.70(%)
  • Suzlon Energy
    61.78 86.04(%)
  • TCS
    3,044.45 3,060.25(%)
  • Bajaj Finance
    886.00 978.59(%)
  • Indian Energy Ex
    132.00 131.50(%)
  • HDFC Bank
    2,019.40 2,035.00(%)
  • Adani Green
    994.45 758.00(%)
  • Infosys
    1,496.60 1,307.10(%)
  • Hind.Aeronautics
    4,411.00 3,045.95(%)
  • Coforge
    1,692.90 1,120.01(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alkem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19299.0
  • ISIN : INE540L01014
5,047.40 36 (0.71%)
  • As on 29 Jul 2025 (EOD)
  • Today’s Low

    4,963.00
  • Today’s High

    5,075.00
  • Open

    4,994.90
  • Perv Close

    5,011.90
  • 52W Low

    4,491.65
  • 52W High

    6,439.90

Key Indicators

  • P/E(TTM)

    26.51

  • Mar.Cap (₹Cr.)

    60,349.24

  • Div & Yield %

    0.89

  • Book Value(₹)

    1,030.56

  • Debt-Equity Ratio

    0.71

  • AGM Date

    28-Jul-2025

  • EPS

    190.41

  • P/E Ratio

    26.51

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    60,349.24

  • RONW (%)

    18.72

  • ROCE (%)

    18.29

Score Board

  • Equity (₹ in Cr.)

    23.91

  • BV (₹)

    1,030.60

  • Sales( ₹ in Cr.)

    8,831.13

  • NP (in Cr.)

    2,276.69

  • NP Var(%)

    26.0

  • Div%

    2250.0

  • CPS (₹)

    214.10

  • EPS (₹)

    190.40

  • Traded Value (₹ in Lakhs)

    60,357.01

  • 52 Week High

    6,439.90

  • 52 Week Low

    4,491.65

  • Price BSE

    5048.0

  • Price NSE

    5,047.00

  • Market Capital( in Cr.)

    60,357.01

  • P/C Ratio

    23.60

  • P/E Ratio

    26.50

  • Price Vs.BV

    190.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 8,831.13 7,972.25 9,054.55 8,829.81 7,219.68 6,677.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 8,831.13 7,972.25 9,054.55 8,829.81 7,219.68 6,677.08
Other Income 698.23 492.63 266.29 199.89 190.01 95.98
Stock Adjustments -56.61 30.85 -257.73 360.90 301.29 33.69
Total Income 9,472.75 8,495.73 9,063.11 9,390.60 7,710.98 6,806.75
EXPENDITURE :            
Raw Materials 2,785.53 2,654.63 3,572.91 3,926.79 2,966.31 2,584.25
Power and Fuel Cost 128.35 123.85 126.32 129.53 100.12 106.08
Employee Cost 1,630.96 1,478.01 1,516.22 1,434.49 1,158.72 1,066.76
Other Manufacturing Expenses 509.57 439.03 361.12 399.80 280.51 276.78
Selling and Administration Expenses 1,669.74 1,617.16 1,739.71 1,438.80 1,007.42 1,160.90
Miscellaneous Expenses -105.83 83.07 103.59 50.94 71.74 48.35
Employee Benefit Expenses 1,630.96 1,478.01 1,516.22 1,434.49 1,158.72 1,066.76
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,618.32 6,395.75 7,419.87 7,380.35 5,584.82 5,243.12
Operating Profit 2,854.43 2,099.98 1,643.24 2,010.25 2,126.16 1,563.63
Interest 76.11 80.07 86.40 37.90 42.93 38.71
Gross Profit 2,778.32 2,019.91 1,556.84 1,972.35 2,083.23 1,524.92
Depreciation 283.61 239.14 229.85 218.98 198.93 186.84
Profit Before Tax 2,494.71 1,780.77 1,326.99 1,753.37 1,884.30 1,338.08
Current Tax 261.10 32.82 227.52 303.82 331.83 246.95
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -47.28 0.80 -35.00 -91.70 -132.61 -173.29
Reported Net Profit 2,280.89 1,747.15 1,134.47 1,541.25 1,685.08 1,264.42
Extraordinary Items 4.20 -57.92 -10.24 1.82 16.49 3.07
Adjusted Net Profit 2,276.69 1,805.07 1,144.71 1,539.43 1,668.59 1,261.35
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -73.21
P & L Balance brought forward 8,640.88 7,431.77 6,823.39 5,700.62 4,350.32 3,517.81
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 502.17 538.04 526.09 418.48 334.78 358.70
P & L Balance carried down 10,419.60 8,640.88 7,431.77 6,823.39 5,700.62 4,350.32
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,250.00 2,000.00 2,500.00 1,700.00 1,500.00 1,250.00
Dividend Per Share(Rs) 45.00 40.00 50.00 34.00 30.00 25.00
Earnings Per Share-Unit Curr 190.79 146.14 94.90 128.92 140.95 105.76
Earnings Per Share(Adj)-Unit Curr 190.79 146.14 94.90 128.92 140.95 105.76
Book Value 1,030.68 882.86 782.09 731.38 637.87 525.34
Book Value(Adj)-Unit Curr 1,030.68 882.86 782.09 731.38 637.87 525.34

Shareholding Pattern

  • Promoter Group

    53.04%

  • Public Share Holding

    46.96%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 63,413,109 53.04 63,413,109 26
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 63,413,109 53.04 63,413,109 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 14 0.00 14 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,891,359 9.11 10,891,359 485
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,331,941 3.62 4,331,941 22
Mutual Funds / UTI 19,934,766 16.67 19,934,766 30
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,799,822 1.51 1,799,822 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 36,957,902 30.91 36,957,902 551
2] Non Institution
Bodies Corporate 216,554 0.18 216,554 680
Clearing Members 57,795 0.05 57,795 8
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 94,583 0.08 94,583 2,477
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 47,260 0.04 47,260 2,151
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 17,141,097 14.34 17,141,097 12
Individuals holding nominal share capital up to Rs. 1 lakh 1,617,600 1.35 1,617,600 73,755
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,521 0.00 2,521 3
Others 533 0.00 533 2
Sub Total 19,193,989 16.05 19,193,989 79,163
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 119,565,000 100.00 119,565,000 79,740

Company Background

Alkem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alkem Laboratories Ltd
  • BSE Code : 19299.0
  • ISIN : INE540L01014
  • Incorporation Year

    1973

  • Registered Office

    Alkem House SenapatiBapat Marg
    Lower Parel, Mumbai,
    Maharashtra-400013

  • Telephone

    91-22-39829999

  • FAX

    91-22-24952955

  • Chairman

    Basudeo N Singh

  • Managing Director

    SANDEEP SINGH

  • Company Secretary

    Manish Narang

  • Auditor

    B S R & Co LLP/Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Alkem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alkem Lab 5,048.05 9,320.50 8,813.44 26.46 20.29
Abbott India 32,886.45 6,684.73 6,409.15 49.41 44.95
Astrazeneca Phar 8,945.00 1,756.92 1,716.29 193.20 32.94
P & G Health Ltd 5,846.65 1,166.89 1,151.26 38.64 39.76
Glaxosmi. Pharma 3,088.80 3,866.05 3,723.49 56.94 58.72
Cipla 1,570.95 20,029.57 19,044.85 23.48 21.40
Amrutanjan Healt 661.15 437.58 421.23 37.61 20.84
Fermenta Biotec. 377.00 442.21 430.53 16.41 17.61
Guj. Themis Bio. 367.70 174.19 169.82 82.08 44.82
Bliss GVS Pharma 155.10 703.42 667.20 23.72 9.16
Ambalal Sarabhai 32.27 19.33 4.04 29.88 2.10